anti-VISTA monoclonal antibody SNS-101
Term · Oncology and biomedicine · MLC-T-ONC-011183
A conditionally active, pH-sensitive human immunoglobulin (Ig) G1 monoclonal antibody directed against the negative immune checkpoint regulatory protein V-domain Ig suppressor of T-cell activation (VISTA; programmed death 1 homolog; PD1H; PD-1H), with potential negative immune checkpoint regulatory and antineoplastic activities. Upon administration, anti-VISTA monoclonal antibody SNS-101 selectively targets, binds to and blocks the VISTA checkpoint within a low, acidic pH tumor microenvironment (TME). This prevents the interaction of VISTA with its receptor PSGL-1 on T cells, inhibits VISTA-mediated signaling, decreases the presence of monocytic myeloid-derived suppressor cells (MDSCs), increases the presence of natural killer cells (NKs), activates dendritic cells (DCs) and abrogates VISTA-induced suppression of T-lymphocyte immune responses. This enhances cytotoxic T-cell infiltration, proliferation, and activation within the TME, increases cytokine production by T cells, and inhibits tumor cell growth. VISTA, a negative checkpoint molecule of immune activation, is highly expressed on myeloid cells, T cells and in several tumor types. It plays a key role in the suppression of T-cell function and tumor immunosuppression.
| Identifier | MLC-T-ONC-011183 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | conditionally active VISTA-blocking antibody SNS-101; VISTA-blocking monoclonal antibody SNS-101 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011183",
"term": "anti-VISTA monoclonal antibody SNS-101",
"field": "Oncology and biomedicine",
"definition": "A conditionally active, pH-sensitive human immunoglobulin (Ig) G1 monoclonal antibody directed against the negative immune checkpoint regulatory protein V-domain Ig suppressor of T-cell activation (VISTA; programmed death 1 homolog; PD1H; PD-1H), with potential negative immune checkpoint regulatory and antineoplastic activities. Upon administration, anti-VISTA monoclonal antibody SNS-101 selectively targets, binds to and blocks the VISTA checkpoint within a low, acidic pH tumor microenvironment (TME). This prevents the interaction of VISTA with its receptor PSGL-1 on T cells, inhibits VISTA-mediated signaling, decreases the presence of monocytic myeloid-derived suppressor cells (MDSCs), increases the presence of natural killer cells (NKs), activates dendritic cells (DCs) and abrogates VISTA-induced suppression of T-lymphocyte immune responses. This enhances cytotoxic T-cell infiltration, proliferation, and activation within the TME, increases cytokine production by T cells, and inhibits tumor cell growth. VISTA, a negative checkpoint molecule of immune activation, is highly expressed on myeloid cells, T cells and in several tumor types. It plays a key role in the suppression of T-cell function and tumor immunosuppression.",
"synonyms": [
"conditionally active VISTA-blocking antibody SNS-101",
"VISTA-blocking monoclonal antibody SNS-101"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-vista-monoclonal-antibody-sns-101/"
}
Record 2,336 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.